moderna

Просмотров: 8,200
66 обсуждают
Paradox1997
·
--
Biotech Bounce: Moderna bStock Gains Steam 🚀 Price action – $MRNAB is trading at $198.28 on Binance Spot, up 3.06 % over the past 24 h. The rally comes as biotech peers rally ahead of the Q3 earnings wave, keeping sector sentiment upbeat. Key levels – Immediate support sits near $192.00, with a secondary floor around $188.00. Resistance looms at $202.50, while the mid‑range pivot is roughly $195.00. Outlook – With momentum building and the recent dip offering a tighter entry, the short‑term bias stays bullish. Dips appear buyable as the stock aims to test the $202.50 ceiling before any pullback. #MRNAB #Moderna #BinanceSquare
Biotech Bounce: Moderna bStock Gains Steam 🚀

Price action – $MRNAB is trading at $198.28 on Binance Spot, up 3.06 % over the past 24 h. The rally comes as biotech peers rally ahead of the Q3 earnings wave, keeping sector sentiment upbeat.

Key levels – Immediate support sits near $192.00, with a secondary floor around $188.00. Resistance looms at $202.50, while the mid‑range pivot is roughly $195.00.

Outlook – With momentum building and the recent dip offering a tighter entry, the short‑term bias stays bullish. Dips appear buyable as the stock aims to test the $202.50 ceiling before any pullback.

#MRNAB #Moderna #BinanceSquare
Moderna Momentum: Coiled for a Breakout on Binance Spot 🚀📊 Price action – Moderna Inc token $MRNAB trades at $241.92 on Binance Spot (MRNAB/USDT), down 4.92 % over the past 24 hours. The dip reflects broader biotech weakness despite a neutral crypto sentiment backdrop. Why it matters – The stock sits ahead of Q2 earnings and a pipeline update on its mRNA vaccine candidates, a catalyst that could swing the sector. Key levels – Immediate support is anchored around $230.00, a low that held during the last correction. Resistance clusters near $250.00, the prior swing high where price has been coiling. The midpoint of the current range sits near $240.50, acting as a short‑term pivot for traders. Outlook – Analyst angle: breakout watch. Price is coiling near the $250 resistance; a decisive volume spike could trigger a bullish breakout. With volume still modest, the short‑term bias remains cautious, awaiting a clear surge before confirming upside. #MRNAB #Moderna #BinanceSquare
Moderna Momentum: Coiled for a Breakout on Binance Spot 🚀📊

Price action – Moderna Inc token $MRNAB trades at $241.92 on Binance Spot (MRNAB/USDT), down 4.92 % over the past 24 hours. The dip reflects broader biotech weakness despite a neutral crypto sentiment backdrop.

Why it matters – The stock sits ahead of Q2 earnings and a pipeline update on its mRNA vaccine candidates, a catalyst that could swing the sector.

Key levels – Immediate support is anchored around $230.00, a low that held during the last correction. Resistance clusters near $250.00, the prior swing high where price has been coiling. The midpoint of the current range sits near $240.50, acting as a short‑term pivot for traders.

Outlook – Analyst angle: breakout watch. Price is coiling near the $250 resistance; a decisive volume spike could trigger a bullish breakout. With volume still modest, the short‑term bias remains cautious, awaiting a clear surge before confirming upside.

#MRNAB #Moderna #BinanceSquare
Moderna bStock Faces Fresh Test of Support 🚧 Price action – $MRNAB is trading at $255.89 on Binance Spot, down 7.74% over the past 24 hours. The candle closed near the lower edge of the recent range, hinting at a defensive stance as sellers press. Why it matters – The biotech sector is awaiting the next wave of mRNA pipeline data, and a sustained dip could pressure broader biotech sentiment ahead of upcoming earnings season. Key levels – Immediate support sits around $250.00, with a secondary floor near $245.00. Resistance looms at $260.00, while the mid‑range pivot is near $257.50, a zone that has acted as a bounce point in prior sessions. Outlook – From a support‑defense perspective, buyers need to hold the $250 floor; failure could open a deeper decline toward $240. A clean hold may set the stage for a rebound toward the $260 ceiling. #MRNAB #Moderna #BinanceSquare
Moderna bStock Faces Fresh Test of Support 🚧

Price action – $MRNAB is trading at $255.89 on Binance Spot, down 7.74% over the past 24 hours. The candle closed near the lower edge of the recent range, hinting at a defensive stance as sellers press.

Why it matters – The biotech sector is awaiting the next wave of mRNA pipeline data, and a sustained dip could pressure broader biotech sentiment ahead of upcoming earnings season.

Key levels – Immediate support sits around $250.00, with a secondary floor near $245.00. Resistance looms at $260.00, while the mid‑range pivot is near $257.50, a zone that has acted as a bounce point in prior sessions.

Outlook – From a support‑defense perspective, buyers need to hold the $250 floor; failure could open a deeper decline toward $240. A clean hold may set the stage for a rebound toward the $260 ceiling.

#MRNAB #Moderna #BinanceSquare
Genome Gains: $MRNAB Holds Steady on Binance Spot 🌐 Price action – $MRNAB is trading at $227.73 on Binance Spot, up 3.78 % in the past 24 h with modest volume. The rally follows a broader biotech bounce as investors price‑roll recent mRNA pipeline optimism. Key levels – Immediate support sits near $220, the prior swing low that anchored the last pull‑back. Mid‑range equilibrium is around $227.5, acting as a pivot for current price action. The nearest resistance cluster is at $235, with a secondary ceiling near $242 should the upside gain momentum. Outlook – Neutral. The token is likely to consolidate within the $220‑$235 range as the market digests sector‑wide data. Traders should wait for a decisive break above $235 or below $220 before committing to a directional bias. #MRNAB #Moderna #BinanceSquare
Genome Gains: $MRNAB Holds Steady on Binance Spot 🌐

Price action – $MRNAB is trading at $227.73 on Binance Spot, up 3.78 % in the past 24 h with modest volume. The rally follows a broader biotech bounce as investors price‑roll recent mRNA pipeline optimism.

Key levels – Immediate support sits near $220, the prior swing low that anchored the last pull‑back. Mid‑range equilibrium is around $227.5, acting as a pivot for current price action. The nearest resistance cluster is at $235, with a secondary ceiling near $242 should the upside gain momentum.

Outlook – Neutral. The token is likely to consolidate within the $220‑$235 range as the market digests sector‑wide data. Traders should wait for a decisive break above $235 or below $220 before committing to a directional bias.

#MRNAB #Moderna #BinanceSquare
Vaccine Vanguard: $MRNAB Gathers Steam 🚀 Price action: $MRNAB trades at $219.78 on Binance Spot (MRNAB/USDT), slipping 0.47 % over the past 24 hours. Why it matters: Moderna stays at the forefront of mRNA therapeutics, and fresh Q3 pipeline data could ignite broader biotech momentum. Key levels: - Support near $215.00, a zone that has held in prior pullbacks. - Mid‑range equilibrium around $220.50, acting as a pivot for short‑term bias. - Resistance at $225.00, the next hurdle before a breakout toward $230+. Short outlook 📈: With neutral market sentiment but underlying sector strength, the dip appears buyable. The analyst angle is bullish continuation – momentum is building, and a bounce off support could set the stage for a renewed upward swing. #MRNAB #Moderna #BinanceSquare
Vaccine Vanguard: $MRNAB Gathers Steam 🚀

Price action: $MRNAB trades at $219.78 on Binance Spot (MRNAB/USDT), slipping 0.47 % over the past 24 hours.

Why it matters: Moderna stays at the forefront of mRNA therapeutics, and fresh Q3 pipeline data could ignite broader biotech momentum.

Key levels:
- Support near $215.00, a zone that has held in prior pullbacks.
- Mid‑range equilibrium around $220.50, acting as a pivot for short‑term bias.
- Resistance at $225.00, the next hurdle before a breakout toward $230+.

Short outlook 📈: With neutral market sentiment but underlying sector strength, the dip appears buyable. The analyst angle is bullish continuation – momentum is building, and a bounce off support could set the stage for a renewed upward swing.

#MRNAB #Moderna #BinanceSquare
🧬 $MRNAB RISES 6.42% — BIOTECH EXPOSURE IS ON THE MOVE! Current Price: $217.67 24H Change: +6.42% $MRNAB is showing a healthy daily gain in this market snapshot, bringing Moderna-linked tokenized stock exposure into focus. • The current move is positive. • Keep an eye on price stability after the rally. • Remember that company news and wider stock-market conditions can affect performance. Important: MRNAB is a bStock product, not a regular crypto token. Understand its structure, risks, and trading hours before taking a position. #MRNAB #Moderna #bStocks #MarketTrends
🧬 $MRNAB RISES 6.42% — BIOTECH EXPOSURE IS ON THE MOVE!

Current Price: $217.67
24H Change: +6.42%

$MRNAB is showing a healthy daily gain in this market snapshot, bringing Moderna-linked tokenized stock exposure into focus.

• The current move is positive.
• Keep an eye on price stability after the rally.
• Remember that company news and wider stock-market conditions can affect performance.

Important: MRNAB is a bStock product, not a regular crypto token. Understand its structure, risks, and trading hours before taking a position.

#MRNAB #Moderna #bStocks #MarketTrends
$MRNAB IS MOVING UP — CAN BUYERS TURN A STEADY GAIN INTO A BIGGER MOVE? Moderna bStocks ($MRNAB) has gained 4.98% over the past 24 hours. The move is more measured than some of the day's biggest gainers, giving traders a reason to watch for a structured continuation rather than chase sudden volatility. The key is to see whether buyers can hold the entry area and push through the next price levels. Trade Setup • Current Price: $215.27 • Buy Zone: $211.00 – $214.00 • Entry Point: Enter only after a confirmed bounce • TP1: $218.00 • TP2: $222.00 • TP3: $228.00 • Stop Loss: $206.50 The Next Decision • A hold above $211 could support a move toward $218. • A clean break above $218 may open the way toward $222. • A drop below $206.50 invalidates the proposed setup. $MRNAB is a tokenized stock product. Verify its relationship to the underlying Moderna share, market hours, liquidity, and product risks before trading. Do not confuse a daily gain with a guaranteed continuation. #MRNAB #Moderna #TokenizedStocks #MarketWatch
$MRNAB IS MOVING UP — CAN BUYERS TURN A STEADY GAIN INTO A BIGGER MOVE?

Moderna bStocks ($MRNAB ) has gained 4.98% over the past 24 hours. The move is more measured than some of the day's biggest gainers, giving traders a reason to watch for a structured continuation rather than chase sudden volatility.

The key is to see whether buyers can hold the entry area and push through the next price levels.

Trade Setup

• Current Price: $215.27
• Buy Zone: $211.00 – $214.00
• Entry Point: Enter only after a confirmed bounce
• TP1: $218.00
• TP2: $222.00
• TP3: $228.00
• Stop Loss: $206.50

The Next Decision

• A hold above $211 could support a move toward $218.
• A clean break above $218 may open the way toward $222.
• A drop below $206.50 invalidates the proposed setup.

$MRNAB is a tokenized stock product. Verify its relationship to the underlying Moderna share, market hours, liquidity, and product risks before trading. Do not confuse a daily gain with a guaranteed continuation.

#MRNAB #Moderna #TokenizedStocks #MarketWatch
·
--
Рост
$MRNA is trading at $206.06, rising 5.18%. The biotech stock is gaining attention as investors monitor developments in vaccines, medical research, and the company's future growth opportunities. Further movement will depend on market sentiment and company-specific developments. $MRNA {future}(MRNAUSDT) #Write2Earn! #MRNA #Moderna #BiotechStocks
$MRNA is trading at $206.06, rising 5.18%. The biotech stock is gaining attention as investors monitor developments in vaccines, medical research, and the company's future growth opportunities. Further movement will depend on market sentiment and company-specific developments.

$MRNA
#Write2Earn! #MRNA #Moderna #BiotechStocks
好数据出炉,股价先崩26%:Moderna癌症疫苗,医生说好,钱说不 上周四,Moderna和默克的个性化黑色素瘤疫苗晚期数据公布:1100多名患者,复发或死亡风险降42%,远处转移风险降38%。 分析师说数据“扎实”,可股价盘中一度暴跌26%,创历史最大单日跌幅,市值一度蒸发约240亿美元。 周五再跌1.25%到200.10美元,周一盘前又跌7.3%到185.45美元,盘中才抢回约198美元。 问题不在数据,在预期:今年以来这只股票涨了570%,市场要的是上次小试验的49%,不是42%。 更扎心的是估值:华尔街目标价普遍在104到138美元,高盛刚上调到137美元,Redburn直接给81美元卖出评级。 我觉得这是典型的“利好出尽”:数据不差,但570%的涨幅已经把好消息吃干了,短期就是挤泡沫,观察不追,失效位是日线收回209.59美元上方。 你觉得这是“好数据被错杀”,还是“涨太多活该跌”? $MRNA $MRK $GS #Moderna #美股 以上不构成投资建议,DYOR,交易有风险。
好数据出炉,股价先崩26%:Moderna癌症疫苗,医生说好,钱说不

上周四,Moderna和默克的个性化黑色素瘤疫苗晚期数据公布:1100多名患者,复发或死亡风险降42%,远处转移风险降38%。

分析师说数据“扎实”,可股价盘中一度暴跌26%,创历史最大单日跌幅,市值一度蒸发约240亿美元。

周五再跌1.25%到200.10美元,周一盘前又跌7.3%到185.45美元,盘中才抢回约198美元。

问题不在数据,在预期:今年以来这只股票涨了570%,市场要的是上次小试验的49%,不是42%。

更扎心的是估值:华尔街目标价普遍在104到138美元,高盛刚上调到137美元,Redburn直接给81美元卖出评级。

我觉得这是典型的“利好出尽”:数据不差,但570%的涨幅已经把好消息吃干了,短期就是挤泡沫,观察不追,失效位是日线收回209.59美元上方。

你觉得这是“好数据被错杀”,还是“涨太多活该跌”?
$MRNA $MRK $GS
#Moderna #美股
以上不构成投资建议,DYOR,交易有风险。
【美股盘前异动 - Moderna $MRNAB 】 癌症疫苗三期成功了,莫德纳 $MRNA 两天跌掉四分之一。盘前 184.47 美元、跌 7.81%,距 10 月 21 日的 245.81 回撤 25%。 第一层原因在跟谁比。三期的复发或死亡风险降 42%,二期是 49%;远处转移降 38%,二期是 59%。相对降幅差了 14% 和 36%。数据是正的。比两年前那版弱。 真正卡住的是总生存。HR 0.77,区间 0.45 到 1.31,跨过 1 就等于没证明。停药率 14.0%,单用 Keytruda 是 8.7%,翻了 1.6 倍。疗效更好,代价是更多人退出。 所以卖方没否定疗效。RBC 说临床上有意义、大概率能获批,瑞银说对肾癌膀胱癌更有信心。 下调的是估值:Brookline 把 2030 年 EPS 从 19.11 砍到 18.19,Redburn 直接降到卖出。这只股年内从 29.49 涨到 200 出头,市值里很大一块押在 mRNA 治癌上。下一个变量是 ESMO 的非小细胞肺癌读数:好,这里错杀;糊,25% 只是开始。 {spot}(MRNABUSDT) #生物科技 #moderna #币安神算子
【美股盘前异动 - Moderna $MRNAB 】
癌症疫苗三期成功了,莫德纳 $MRNA 两天跌掉四分之一。盘前 184.47 美元、跌 7.81%,距 10 月 21 日的 245.81 回撤 25%。

第一层原因在跟谁比。三期的复发或死亡风险降 42%,二期是 49%;远处转移降 38%,二期是 59%。相对降幅差了 14% 和 36%。数据是正的。比两年前那版弱。

真正卡住的是总生存。HR 0.77,区间 0.45 到 1.31,跨过 1 就等于没证明。停药率 14.0%,单用 Keytruda 是 8.7%,翻了 1.6 倍。疗效更好,代价是更多人退出。

所以卖方没否定疗效。RBC 说临床上有意义、大概率能获批,瑞银说对肾癌膀胱癌更有信心。

下调的是估值:Brookline 把 2030 年 EPS 从 19.11 砍到 18.19,Redburn 直接降到卖出。这只股年内从 29.49 涨到 200 出头,市值里很大一块押在 mRNA 治癌上。下一个变量是 ESMO 的非小细胞肺癌读数:好,这里错杀;糊,25% 只是开始。

#生物科技 #moderna #币安神算子
·
--
Падение
🚨 $MRNAB DROPS 19.21% IN 24 HOURS! 📉 {spot}(MRNABUSDT) 💰 Price: $194.41 🔴 MRNAB faces heavy selling pressure after falling sharply from recent highs. Can buyers defend $190, or will the decline continue? 📊 BOUNCE BACK OR MORE DOWNSIDE? 👀 💬 BULLISH 🟢 or BEARISH 🔴? Share your prediction! ⚠️ High volatility — manage your risk. #MRNAB #Moderna #Crypto #Trading
🚨 $MRNAB DROPS 19.21% IN 24 HOURS! 📉

💰 Price: $194.41

🔴 MRNAB faces heavy selling pressure after falling sharply from recent highs. Can buyers defend $190, or will the decline continue?

📊 BOUNCE BACK OR MORE DOWNSIDE? 👀

💬 BULLISH 🟢 or BEARISH 🔴? Share your prediction!

⚠️ High volatility — manage your risk.

#MRNAB #Moderna #Crypto #Trading
Moderna 收在242美元,华尔街平均目标价才101,股价是目标价的2.4倍,周六数据前我不追 看见了:周二 Moderna 涨6.7%,盘中243.98创52周新高。 一年前最低收盘才22.36,现在翻了10倍多;8月19日三期初步结果出来,一天涨了177%。 和默沙东合作的黑色素瘤个性化疫苗,完整三期数据10月24日22:30(北京时间)在ESMO公布。 我觉得好消息大半已经在价格里,数据只要不够惊艳,就容易见光死;过去90天公司内部人还卖了约3390万美元股票。 我怎么做:不追,也不提前做空。 数据后站稳243.98再看;跌破10月16日低点208.92,算预期打完。 周六晚数据出来前,你会拿着 Moderna 过周末吗,拿还是不拿? $MRNA $MRK #Moderna #癌症疫苗
Moderna 收在242美元,华尔街平均目标价才101,股价是目标价的2.4倍,周六数据前我不追

看见了:周二 Moderna 涨6.7%,盘中243.98创52周新高。
一年前最低收盘才22.36,现在翻了10倍多;8月19日三期初步结果出来,一天涨了177%。
和默沙东合作的黑色素瘤个性化疫苗,完整三期数据10月24日22:30(北京时间)在ESMO公布。

我觉得好消息大半已经在价格里,数据只要不够惊艳,就容易见光死;过去90天公司内部人还卖了约3390万美元股票。

我怎么做:不追,也不提前做空。
数据后站稳243.98再看;跌破10月16日低点208.92,算预期打完。

周六晚数据出来前,你会拿着 Moderna 过周末吗,拿还是不拿?

$MRNA $MRK
#Moderna #癌症疫苗
#ModernaRisesOver12% Moderna (MRNA) shares shot up more than 12% yesterday, closing at about $67. Why the big jump? > The company shared exciting updates on new mRNA treatments for cancer prevention, autoimmune diseases and more. > Good news from the FDA on their flu vaccine also helped boost confidence. This is a big win for the biotech company, which has been working hard to expand beyond COVID vaccines. Investors are feeling optimistic about the future! What do you think — is this the start of something bigger for Moderna? #Moderna #Stocks #MRNA
#ModernaRisesOver12%
Moderna (MRNA) shares shot up more than 12% yesterday, closing at about $67.

Why the big jump?

> The company shared exciting updates on new mRNA treatments for cancer prevention, autoimmune diseases and more.
> Good news from the FDA on their flu vaccine also helped boost confidence.

This is a big win for the biotech company, which has been working hard to expand beyond COVID vaccines. Investors are feeling optimistic about the future!

What do you think — is this the start of something bigger for Moderna?
#Moderna #Stocks #MRNA
MRNAonAlpha
MRNAUS+0,03%
·
--
Рост
$MRNAB is stabilizing near support levels after a notable pull-back, showing signs of buyer defense around current prices. A successful consolidation here could ignite a relief bounce to challenge upper supply levels. Target 1: 148.00 Target 2: 152.00 Target 3: 156.00 #MRNAB #Moderna #Crypto $TUT {future}(TUTUSDT) $ZEC {future}(ZECUSDT) {spot}(MRNABUSDT)
$MRNAB is stabilizing near support levels after a notable pull-back, showing signs of buyer defense around current prices. A successful consolidation here could ignite a relief bounce to challenge upper supply levels.

Target 1: 148.00 Target 2: 152.00 Target 3: 156.00

#MRNAB #Moderna #Crypto
$TUT
$ZEC
$MRNAon has displayed a powerful initial breakout, pumping over 12% to test a high near 159.42 before encountering quick resistance. Price has since retraced on the 15m chart and is currently forming a tight, low-volatility consolidation range right around the 145.66 level. A successful defense of this base near 142.40 will be crucial for buyers to build momentum for another leg upward. Target 1: 151.00 Target 2: 159.40 Target 3: 168.00 #MRNAon #Moderna #CryptoTrading #Altcoins $TRUMP {future}(TRUMPUSDT) {alpha}(560x01486675da0764ee780ea7cb65c33062e9b2d28c) $ZEC {future}(ZECUSDT)
$MRNAon has displayed a powerful initial breakout, pumping over 12% to test a high near 159.42 before encountering quick resistance. Price has since retraced on the 15m chart and is currently forming a tight, low-volatility consolidation range right around the 145.66 level. A successful defense of this base near 142.40 will be crucial for buyers to build momentum for another leg upward.

Target 1: 151.00 Target 2: 159.40 Target 3: 168.00

#MRNAon #Moderna #CryptoTrading #Altcoins
$TRUMP
$ZEC
·
--
Рост
🚨 MODERNA SURGES 14% AFTER CANCER-THERAPY BREAKTHROUGH 📈 Moderna jumped 14.36% after Moderna and Merck reported positive Phase III results for their personalized mRNA cancer therapy, intismeran autogene, in high-risk melanoma. 🏦 Major banks responded by raising Moderna’s price targets, with Bank of America moving from $40 to $170 and Piper Sandler from $77 to $167. 🎯 TRADING VIEW: BUY 📈 The strong clinical results and major target upgrades create a bullish catalyst, but traders should monitor whether momentum holds after the sharp rally. ❓ Can Moderna extend this breakout? "CLICK ON THE BELOW YELLOW COIN TAG TO GO TO DESIRED TRADING PAGE TO GET BENEFIT TRADE"$MRNA {future}(MRNAUSDT) #moderna #MRNAon
🚨 MODERNA SURGES 14% AFTER CANCER-THERAPY BREAKTHROUGH 📈
Moderna jumped 14.36% after Moderna and Merck reported positive Phase III results for their personalized mRNA cancer therapy, intismeran autogene, in high-risk melanoma.
🏦 Major banks responded by raising Moderna’s price targets, with Bank of America moving from $40 to $170 and Piper Sandler from $77 to $167.
🎯 TRADING VIEW: BUY 📈
The strong clinical results and major target upgrades create a bullish catalyst, but traders should monitor whether momentum holds after the sharp rally.
❓ Can Moderna extend this breakout? "CLICK ON THE BELOW YELLOW COIN TAG TO GO TO DESIRED TRADING PAGE TO GET BENEFIT TRADE"$MRNA
#moderna #MRNAon
·
--
هذا أمر مذهل. ارتفع سهم شركة "موديرنا" (Moderna) بنحو 150% اليوم، ليقفز إلى المركز الثاني ضمن قائمة الأسهم الأفضل أداءً في مؤشر "إس آند بي 500" (S&P 500) لعام 2026. وبات السهم يحتل هذا الموقع المتميز بمفرده في قائمة تهيمن عليها شركات الذكاء الاصطناعي، ولا يسبقه سوى سهم شركة "سانديسك" (Sandisk). {stock_us}(MRNA.US) #stocks #moderna #SNDK #S&P500 {stock_us}(DELL.US)
هذا أمر مذهل. ارتفع سهم شركة "موديرنا" (Moderna) بنحو 150% اليوم، ليقفز إلى المركز الثاني ضمن قائمة الأسهم الأفضل أداءً في مؤشر "إس آند بي 500" (S&P 500) لعام 2026. وبات السهم يحتل هذا الموقع المتميز بمفرده في قائمة تهيمن عليها شركات الذكاء الاصطناعي، ولا يسبقه سوى سهم شركة "سانديسك" (Sandisk).


#stocks #moderna #SNDK #S&P500
SNDKB+1,65%
DELLUS-8,40%
MRNAUS+0,03%
·
--
Рост
Проверено
🚨 JUST IN: $MRNA.US Moderna is EXPLODING 🚀 The stock surges 130%+ after its cancer vaccine showed signs of preventing melanoma from spreading. 🧬💉 This could be a HUGE breakthrough for cancer treatment. 👀 Biotech just got VERY interesting. 🚀📈 #cancer #moderna $BIO {stock_us}(MRNA.US) {spot}(BIOUSDT)
🚨 JUST IN: $MRNA.US Moderna is EXPLODING 🚀

The stock surges 130%+ after its cancer vaccine showed signs of preventing melanoma from spreading. 🧬💉

This could be a HUGE breakthrough for cancer treatment. 👀

Biotech just got VERY interesting. 🚀📈
#cancer #moderna $BIO
BIO+3,53%
MRNAUS+0,03%
·
--
Рост
قبل ٧ ساعات فقط جلبت لكم خبر رائع سيرفع سهم شركة $MRNA.US وكان السعر حينها 120 $ , وأخبرتكم أنه سيرتفع كما هو موضح 👇 والآن وصل سعر السهم 194 $ 🔥👌🚀🚀 #stocks #MRNA #moderna #Stocks_DAB3 {stock_us}(MRNA.US)
قبل ٧ ساعات فقط جلبت لكم خبر رائع سيرفع سهم شركة $MRNA.US وكان السعر حينها 120 $ , وأخبرتكم أنه سيرتفع كما هو موضح 👇 والآن وصل سعر السهم 194 $ 🔥👌🚀🚀
#stocks #MRNA #moderna #Stocks_DAB3
DAB3_1997
·
--
Рост
سهم $MRNA.US يرتفع بقوة بفضل النتائج الناجحة للقاح ضد سرطان الميلانوما. 💉
#stocks #stoksDAB3 #MRNA
MRNAUS+0,03%
·
--
Рост
قفز سهم شركة "موديرنا" (MRNA) بنسبة 150% - محققاً أفضل أداء يومي في تاريخه - بعد أن أظهر لقاح للسرطان إمكانيةً في منع تكرار الإصابة بالورم الميلانيني. 📈 📈 {stock_us}(MRNA.US) #stocks #stocksDAB3 #stockDAB3 #moderna
قفز سهم شركة "موديرنا" (MRNA) بنسبة 150% - محققاً أفضل أداء يومي في تاريخه - بعد أن أظهر لقاح للسرطان إمكانيةً في منع تكرار الإصابة بالورم الميلانيني. 📈 📈
#stocks #stocksDAB3 #stockDAB3 #moderna
MRNAUS+0,03%
Войдите, чтобы посмотреть больше материала
Присоединяйтесь к пользователям криптовалют по всему миру на Binance Square
⚡️ Получайте новейшую и полезную информацию о криптоактивах.
💬 Нам доверяет крупнейшая в мире криптобиржа.
👍 Получите достоверные аналитические данные от верифицированных создателей контента.
Эл. почта/номер телефона